Mitchell P. Kopin 13D and 13G filings for Atossa Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-01-15 4:09 pm Purchase |
2020-01-06 | 13G | Atossa Therapeutics, Inc. ATOS |
Mitchell P. Kopin | 3,749,923 4.990% |
1,499,923 (+66.66%) |
Filing |
| 2020-12-28 06:14 am Purchase |
2020-12-17 | 13G | Atossa Therapeutics, Inc. ATOS |
Mitchell P. Kopin | 2,250,000 4.900% |
2,150,032 (+2150.72%) |
Filing |